Research funder · United States
Alzheimer's Association
A non-profit American health organization which focuses Alzheimer's disease
- Grants since 2016
- 1 779
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 7 372
- Funded works, all time
- 14.6k
Grants
2026 · research · AARF
Uncovering SNAP91’s Role in R406W Tauopathy and Synaptic Dysfunction
Catherine Hamann · Regenerative Research Foundation
2026 · research · AARF
Utilization of CAR-T cell therapy in Alzheimer's disease
Pavle Boskovic · Washington University in St. Louis
2026 · research · PTC-EMT
IND readiness for PRM914 a Novel Oral Gut-Brain treatment for Alzheimer's
Mark Heiman · Pramana Pharmaceuticals Inc
2026 · research · AARF
The impact of Alzheimer’s risk genes EIF2B2 & EIF2B3 on microglia function
Francesca Garretti · Icahn School of Medicine at Mount Sinai
2026 · research · BFDN
PRISM: Profiling Risk, Imaging and Social Mechanisms of Alzheimer's Disease
Esiaka Darlingtina · University Of Kentucky Research Foundation
2026 · research · PTC
Creatine-Augmented Exercise for Neuroprotection in Early AD patients
Luis Soto-Rojas · Universidad Nacional Autónoma de México
2026 · research · AARG
Diversity in Alzheimer’s Disease Biomarkers: A Population-Based Approach
Andrea L. Benedet · University of Gothenburg
2026 · research · ZEN
Development of EV-based biomarkers for AD and related disorders
Tsuneya Ikezu · Mayo Clinic
2026 · research · AACSF
Precision Neuropathology: Proteomic Clustering of Amyloid Plaques
Kaleigh Roberts · Washington University in St. Louis
2026 · research · BFDN
Uganda Aging and Dementia Cohort Study
Jeremy Tanner · The University of Texas at San Antonio Health Science Center
2026 · research · AARF
Ketolytic Enzymes to Reprogram Brain Bioenergetics in Alzheimer’s Disease
Taylor Kelty · University of Missouri
2026 · research · BFDN
Cytokines as Neuromodulators in Alzheimer’s Disease
Victor Matheus · Icahn School of Medicine at Mount Sinai
2026 · research · AARF
Identifying time windows and pathways for delaying AD age-at-onset
Emma Coomans · Amsterdam University Medical Centers
2026 · research · AARG
The Role of Oligodendrocyte Precursor Cells in Alzheimer's Disease
Allison Bond · Icahn School of Medicine at Mount Sinai
2026 · research · AARG
Metals and Midlife Brain Aging in US Hispanic/Latino Adults
Julia Bauer · University of Chicago
2026 · research · AARG
Closing Rural-Urban Dementia Gaps Through Cardiovascular Risk Reduction
Jinyi Zhu · Vanderbilt University Medical Center
2026 · research · AARG
Decoding Synergistic Enhancer Hub Alterations in Alzheimer’s Disease
Yidan Sun · Washington University in St. Louis
2026 · research · AARG
Amyloid-Related Imaging Abnormalities, risk, clinical impact and monitoring
Jorge Llibre Guerra · Washington University in St. Louis
2026 · research · BFDN
Ethnoracial Impact on Extracellular Vesicle Biomarkers for AD Diagnosis
Charisse Winston · Alzheimer's Therapeutic Research Institute
2026 · research · BFDN
Molecular mediators of cardiometabolic risk factors and Alzheimer’s disease
Daniel Panyard · Stanford University
2026 · research · AARF
Non-Invasive Intranasal Delivery of Painless NGF for Alzheimer’s Disease
Muhammad Faisal · Karolinska Institutet
2026 · research · BFDN
Validating cyclooxygenase-1 PET as a biomarker for Alzheimer's disease
Min-Jeong Kim · Stony Brook University
2026 · research · PTC-EMT
Targeting MAPT knockdown by a unique siRNA platform to treat Alzheimer's
Anindya Bhattacharya · Switch Therapeutics, Inc.
2026 · research · PTC
A Phase 2A Trial of ALX-001 (BMS-984923)
Timothy Siegert · Allyx Therapeutics, Inc
2025 · research · AARG
Delineating the neuroprotective role of KIBRA across tauopathies
Kaitlin Casaletto · Regent University
2025 · research · AARF
Local or global: Differential effects across ancestry of APOE on the brain
Tavia Evans · Radboud University Medical Center
2025 · research · ABA
AD-protective regulatory APOE variation in ethnically diverse populations
Olena Korvatska · University of Washington
2025 · research · AARF
CD33 genotype and microglial metabolism in Alzheimer’s disease
Kirstin Tamucci · Columbia University Irving Medical Center
2025 · research · AARG-D
Intranasal TREM2 mRNA Delivery to Boost Microglia For Alzheimer's Disease
Jingjing Gao · University of Massachusetts Amherst
2025 · research · ABA
The Impact of the APOE Genotype on Primary Taupathies
Alberto Serrano-Pozo · Massachusetts General Hospital
2025 · research · AARG
Role of APOE4-driven microglial mitochondrial dysfunction
Andrew Mendiola · University Of California
2025 · research · AARF-D
Developing Space-Driven Neuro-Immune Assembloids to Uncover AD Mechanisms
Natalia Chermont Dos Santos Moreira · University of California San Diego
2025 · research · AARF
Functional and transcriptional characterization of TMEM106B in tauopathy
Jacob Dundee · Washington University in St. Louis
2025 · research · VCID-UMD
Mechanistic investigation of cerebrovascular pathology in AD
Adam Brickman · Columbia University
2025 · research · ZEN
Defining Short RNA Therapeutics that Reverse TDP-43 Proteinopathy
James Shorter · University of Pennsylvania
2025 · research · VCID-UMD
Brain fibroblast dysfunction contributes to vascular pathology in AD
Stephanie Bonney · University Of Colorado Denver, Amc And Dc
2025 · research · ABA
Deciphering the Apoe Regulatory Networks for Network for Generation Immunotherapies in Alzheimer's Disease
Ido Amit · Weizmann Institute of Science
2025 · research · VCID-UMD
Arterial hypertension at the crossroad of VCID and AD
Costantino Iadecola · Weill Cornell Medicine
2025 · research · ABA
Decoding APOE4 in Alzheimer's: Astrocyte Cholesterol and Oxysterol Pathways
Irundika Dias · Aston University
2025 · research · AARF-D
Financial and Legal Planning in Dementia Care for Diverse Caregivers
Jasmine Santoyo-Olsson · Regent University